RemeGen Co., Ltd. provided earnings guidance for the period from January to September 2021. For the period, the company is expected to record an operating revenue of approximately RMB 110 million to RMB 120 million for the period from January to September 2021, representing a year-on-year increase of approximately 5,039.7% to 5,506.9%; the net loss attributable to the shareholders of the parent company is expected to be RMB 690 million to RMB 680 million, with a year-on-year increase of 59.2% to 61.5%.